ESTIMATING THE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION CURVE OF INTRAVENOUS-DRUG-USERS IN LOMBARDIA, ITALY

被引：4
|
作者：
SALVAGGIO, A
机构：
[1] Istituto di Igiene e Medicina Preventiva, Università degli Studi di Milano, Milano
来源：
EUROPEAN JOURNAL OF EPIDEMIOLOGY | 1995年 / 11卷 / 02期
关键词：
BACKCALCULATION; HUMAN IMMUNODEFICIENCY VIRUS; INTRAVENOUS DRUG USERS;
D O I：
10.1007/BF01719476
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
We present a model to estimate the infection curve of the human immunodeficiency virus in intravenous drug users in Lombardia. We based estimates on AIDS incidence data, according to a backcalculation model accounting for 'therapy' and changes in the surveillance definition of AIDS.
引用
收藏
页码：127 / 131
页数：5
相关论文
共 50 条
  • [31] DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION BY POLYMERASE CHAIN-REACTION IN A COHORT OF SERONEGATIVE INTRAVENOUS-DRUG-USERS
    FARZADEGAN, H
    VLAHOV, D
    SOLOMON, L
    MUNOZ, A
    ASTEMBORSKI, J
    TAYLOR, E
    BURNLEY, A
    NELSON, KE
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02): : 327 - 331
  • [32] FREQUENCY OF LEFT-VENTRICULAR DYSFUNCTION AND OTHER ECHOCARDIOGRAPHIC ABNORMALITIES IN HUMAN-IMMUNODEFICIENCY-VIRUS SERONEGATIVE INTRAVENOUS-DRUG-USERS
    WILLOUGHBY, SB
    VLAHOV, D
    HERSKOWITZ, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (05): : 446 - 447
  • [33] HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I DISEASE IN ARGENTINE INTRAVENOUS-DRUG-USERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    ZALA, C
    ZAPIOLA, I
    BOUZAS, MB
    BENETUCCI, J
    LOPEZ, L
    GALLO, D
    HANSON, C
    MUCHINIK, GR
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (08): : 870 - 871
  • [34] ASSOCIATION OF DRUG INJECTION PATTERNS WITH ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AMONG INTRAVENOUS-DRUG-USERS IN BALTIMORE, MARYLAND
    VLAHOV, D
    MUNOZ, A
    ANTHONY, JC
    COHN, S
    CELENTANO, DD
    NELSON, KE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (05) : 847 - 856
  • [35] BEHAVIORAL RISK-FACTORS AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PREVALENCE AMONG INTRAVENOUS-DRUG-USERS IN PUERTO-RICO
    ROBLES, RR
    COLON, HM
    SAHAI, H
    MATOS, TD
    MARRERO, CA
    REYES, JC
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (05) : 531 - 540
  • [36] DIFFERENCES IN RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION AMONG MALE AND FEMALE INTRAVENOUS-DRUG-USERS
    SOLOMON, L
    ASTEMBORSKI, J
    WARREN, D
    MUNOZ, A
    COHN, S
    VLAHOV, D
    NELSON, KE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (08) : 892 - 898
  • [37] DIFFERENCES IN RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION AMONG MALE AND FEMALE INTRAVENOUS-DRUG-USERS
    NICOLOSI, A
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (02) : 188 - 189
  • [38] Hepatitis G virus infection in intravenous drug users with or without human immunodeficiency virus infection
    Campo, N
    Brizzolara, R
    Sinelli, N
    Puppo, F
    Campelli, A
    Indiveri, F
    Picciotto, A
    HEPATO-GASTROENTEROLOGY, 2000, 47 (35) : 1385 - 1388
  • [39] INFECTIVE ENDOCARDITIS IN INTRAVENOUS-DRUG-USERS - A COMPARISON OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-NEGATIVE AND 1-POSITIVE PATIENTS
    NAHASS, RG
    WEINSTEIN, MP
    BARTELS, J
    GOCKE, DJ
    JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04): : 967 - 970
  • [40] SEROPREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II INFECTION, WITH OR WITHOUT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COINFECTION, AMONG US INTRAVENOUS-DRUG-USERS
    BRIGGS, NC
    BATTJES, RJ
    CANTOR, KP
    BLATTNER, WA
    YELLIN, FM
    WILSON, S
    RITZ, AL
    WEISS, SH
    GOEDERT, JJ
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01): : 51 - 58
12345